Boston Scientific Corporation (NYSE:BSX) – the science of healing
Over the years, Boston Scientific Corporation (NYSE: BSX) has consistently demonstrated its commitment towards the health of women’s. On 3 June it announced a grant of over $1M to the Pelvic Floor Disorders Network, for its SUPeR clinical-trial. This study will measure the treatment outcomes of a couple of different surgical-options for women who suffer from a form of pelvic organ prolapse, uterine prolapse.
What are pelvic floor disorders?
In the United States alone, an estimated 28 million women suffer from at least one form of pelvic floor disorder. Urinary incontinence is the inability to hold any urine. Pelvic organ prolapse occurs when the muscles and tissues of the pelvic floor are unable to support pelvic organs. This resulting in the dropping or “sagging” of organs such as the uterus, rectum or bladder. Women tend to suffer in silence primarily due to the embarrassment factor. In pelvic floor disorder, the pelvic floor muscles tighten, spasm or may be too loose. The spasms may cause stabbing and shooting pelvic pain. The cause of pelvic floor dysfunction has not been deciphered yet. So also, there is no specific cure for it.
The pelvic floor
Everyone has a pelvic floor. However very few people pay attention to it till the time they suffer from some symptoms in their pelvic region. Most people will breeze through life without really thinking about the pelvic floor but for those who suffer from pelvic floor dysfunction, getting through every day can seem like an uphill task.
Currently there is no real cure for pelvic floor disorders but there are diffrent treatments available.
Companies such as Boston Scientific Corporation (NYSE:BSX) have, in a steadfast manner worked in this area of women’s health. The company has been transforming lives by developing numerous medical solutions. It has been a global leader in the medical technology space for more than three decades.